We then employed the resulting LV, hereon TA33, alone or in combination with LVs driving the expression of IFNα and IL-12, hereon TA33.Combo, to treat mice that were challenged with AKTPF CRC cells via intrasplenic injection (Fig. 5H). This evidence concerns the gene IFNA1 and colorectal carcinoma.